GlassScriptPhysician profile
Jayme L Yocom
NPI 1578903639
$9,070.26
in general payments reported to CMS, 2019-2025
34 companies · $1,391 in 2025
The $1,391 reported for 2025 was more than what 90% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $264 · 2022: $1,104 · 2023: $3,565 · 2024: $2,746 · 2025: $1,391.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,654 · Travel and Lodging: $1,958 · Education: $90.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,654.26 |
| Travel and Lodging | $1,958.05 |
| Education | $90.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,508.71 | 2021-2025 | Synchromedii, Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Abbvie INC. | $773.77 | 2021-2025 | |
| Saluda Medical Americas, INC. | $683.83 | 2023-2025 | Evoke, Evoke Scs |
| Boston Scientific Corporation | $321.77 | 2023-2025 | General - Pain Management |
| Pfizer INC. | $319.64 | 2023-2025 | |
| Scilex Pharmaceuticals INC. | $265.45 | 2023-2025 | Ztlido |
| Collegium Pharmaceutical, INC. | $253.16 | 2024-2025 | Xtampza |
| Tersera Therapeutics LLC | $215.13 | 2022-2025 | Prialt |
| Nalu Medical, INC. | $205.38 | 2023-2025 | Nalu Neurostimulation System |
| Grt US Holding, INC. | $196.83 | 2021-2022 | |
| Spr Therapeutics, INC | $195.22 | 2023-2025 | Sprint Pns System |
| Amgen INC. | $194.27 | 2021-2022 | |
| Nevro Corp. | $190.87 | 2022-2024 | Senza |
| Biohaven Pharmaceutical Holding Company LTD. | $178.00 | 2022 | |
| Averitas Pharma INC. | $175.49 | 2023-2024 | Qutenza |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz Pharmaceuticals, LLC | $175.00 | 2022-2024 | Xeomin |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $164.43 | 2022-2024 | Relistor |
| Vertos Medical, INC. | $149.81 | 2023-2024 | Mild Device Kit |
| Relievant Medsystems, INC. | $133.33 | 2022-2023 | Intracept |
| Biohaven Pharmaceuticals, INC. | $123.75 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $104.70 | 2025 | |
| Ibsa Pharma INC. | $92.65 | 2024-2025 | Licart, Tirosint, Flector |
| Pacira Pharmaceuticals Incorporated | $82.82 | 2024-2025 | Zilretta, Iovera, Exparel |
| Bioventus LLC | $75.64 | 2023 | Durolane |
| Sanofi-Aventis U.S. LLC | $64.87 | 2022-2023 | |
| Globus Medical, INC. | $54.06 | 2025 | Senza |
| Biodelivery Sciences International, INC. | $43.94 | 2021 | |
| Si-Bone, INC. | $25.97 | 2024 | |
| Curonix LLC | $22.91 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Alnylam Pharmaceuticals INC. | $19.42 | 2022 | |
| Allergan, INC. | $15.83 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $15.57 | 2025 | Libtayo |
| Lilly USA, LLC | $14.59 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $13.45 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jayme Yocom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.